Stay updated on Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical-trial page displays the completed KEYNOTE-061 study record, comparing pembrolizumab with paclitaxel for advanced gastric or gastroesophageal junction cancer. It includes study eligibility, treatment arms, outcome measures, publications, and supporting documents.
    Difference
    63%
    Check dated 2026-11-07T12:40:03.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:24:29.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH-wide announcement about updated terminology for artificial intelligence appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T12:59:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:15:24.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:56:10.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the study details with a generic error screen. This indicates an access issue rather than a substantive content update on the page.
    Difference
    20%
    Check dated 2026-09-19T19:22:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.